Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Moleculin Biotech, Inc.MBRX · Entity 7886 | Director | May 05, 2017 | May 05, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Moleculin Biotech, Inc.
Report date May 05, 2017 · Filed May 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
After 2017-05-05 transaction · row 1
1 source rowRow 1 · 2017-05-05 · Purchase · Acquired 1,000 · Balance 1,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2017 Filed May 5, 2017 16:30 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | PurchaseCommon Stock | 1,000 | $0.82 | $820.00 |
DisclosureSEC source: 0001144204-17-024864 · v466235_4.xml · nonDerivative · entry 1 Northcut Jacqueline · CIK 0001674644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 20:58 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantOption to purchase common stock · Derivative | 20,000 | Not disclosed Strike: $5.71 | Not disclosed |
DisclosureSEC source: 0001144204-16-125634 · v449473_4.xml · derivative · entry 1 Northcut Jacqueline · CIK 0001674644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-23 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.